îãŠã©ãããªã¹ãã«è¿œå
çµå€Â 09-24 16:00ïŒETïŒ
476.24MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
NPCE 財åæ
å ±
ã¹ããŒãæè³å®¶åãã«èšèšããããªãŒã«ã€ã³ã¯ã³ã®ããŒã¿ããã·ã¥ããŒãã§ãNeuropace Incã®è²¡åç¶æ³ã確èªã§ããŸãããã®ãã©ãããã©ãŒã ã¯ãè€éãªè²¡åè«žè¡šãæŽçããŠã«ã¹ã¿ãã€ãºå¯èœãªãã¥ãŒã«ãã詳现ãªè²¡ååæãæäŸããŸããææ°ã®å¹ŽåºŠè²¡åå ±åæžã«ã¢ã¯ã»ã¹ããããæçèšç®æžã貞å察ç
§è¡šããã£ãã·ã¥ãããŒèšç®æžã䜿ã£ãŠååæããšã®ããã©ãŒãã³ã¹ãåæããããšãã§ããŸãããªã¢ã«ã¿ã€ã ã®è²¡åææšãæå
ã«çœ®ããŠãäŒæ¥ã®åžå Žå¥åº·ç¶æ
ãç¶ç¶çã«ç£èŠããããšããããŸã§ä»¥äžã«ç°¡åã«ãªããŸããã
éèŠãªè²¡åæ¯ç
1æ ªåœããå©çïŒEPSïŒ
-0.65
èªå·±è³æ¬å©çç
-111.38%
ç·è³ç£å©çç
-20.63%
財å諞衚ã®ãã€ã©ã€ã
ãããã質å
Neuropace Incã®å£²äžé«ã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšã売äžé«ã¯99.99Mã§ãåå¹Žåææ¯79.91Mã§ããã
Neuropace Incã®æµåè³ç£ã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãæµåè³ç£ã¯94.07Mã§ãå幎æ¯15.66ã®å€åããããŸããã
Neuropace Incã®ç·è³ç£ã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è³ç£ã¯105.56Mã§ãåå¹Žåææ¯11.54ã§ããã
Neuropace Incã®ç·è² åµã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è² åµã¯86.53Mã§ãåå¹Žåææ¯-0.12ã§ããã
Neuropace Incã®èªå·±è³æ¬ã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãèªå·±è³æ¬ã¯19.03Mã§ãåå¹Žåææ¯137.50ã§ããã
Neuropace Incã®å¶æ¥å©çã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãå¶æ¥å©çïŒNet Operating IncomeïŒã¯-16.34Mã§ãåå¹Žåææ¯24.61ã§ããã
Neuropace Incã®çŽæè³ã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽæè³ã¯-332.00Kã§ãå幎æ¯-103.69ã®å€åããããŸããã
Neuropace Incã®çŽè³é調éã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽè³é調éã¯19.60Mã§ãå幎æ¯352.97ã®å€åããããŸããã
Neuropace Incã®1æ ªåœããå©çïŒEPSïŒã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšã1æ ªåœããå©çïŒEPSïŒã¯-0.66ã§ãå幎æ¯29.60ã®å€åããããŸããã
Neuropace Incã®çŽå©çã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽå©çã¯-21.46Mã§ãå幎æ¯20.91ã®å€åããããŸããã
Neuropace Incã®çŽå©ççã¯ã©ã®ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãçŽå©ççã¯-21.47ã§ãå幎æ¯36.80ã®å€åããããŸããã
Neuropace Incã®ç²å©ççã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç²å©ççã¯77.23ã§ãå幎æ¯4.45ã®å€åããããŸããã
Neuropace Incã®è² 嵿¯çã¯ã©ã®ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãè² åµæ¯çã¯55.78ã§ãå幎æ¯-11.31ã®å€åããããŸããã
Neuropace Incã®æ ªäž»è³æ¬å©ççïŒROEïŒã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãæ ªäž»è³æ¬å©ççïŒROEïŒã¯-158.74ã§ãå幎æ¯16.17ã®å€åããããŸããã
Neuropace Incã®ç·è³ç£å©ççïŒROAïŒã¯ãããã§ããïŒ
îNeuropace Incã®FY2025ã®æ±ºç®å ±åã«ãããšãç·è³ç£å©ççïŒROAïŒã¯-21.44ã§ãå幎æ¯20.09ã®å€åããããŸããã